Rain Therapeutics Inc.
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Rain Therapeutics Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Rain Therapeutics Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Rain Therapeutics Inc..